{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:13:31Z","timestamp":1786986811081,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.cjca.2012.12.014","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T00:21:45Z","timestamp":1362615705000},"page":"1110-1117","source":"Crossref","is-referenced-by-count":8,"title":["Thrombocytopenia, Dual Antiplatelet Therapy, and Heparin Bridging Strategy Increase Pocket Hematoma Complications in Patients Undergoing Cardiac Rhythm Device Implantation"],"prefix":"10.1016","volume":"29","author":[{"given":"Huang-Chung","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Lung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bih-Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hsien","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Ping","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Li","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mien-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2012.12.014_bib1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/CIRCEP.111.969105","article-title":"Meta-analysis of bleeding complications associated with cardiac rhythm device implantation","volume":"5","author":"Bernard","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2012.12.014_bib2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1378\/chest.126.4.1177","article-title":"Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet\/anticoagulation therapy","volume":"126","author":"Wiegand","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2012.12.014_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/hrt.2008.151985","article-title":"Risk factors and time delay associated with cardiac device infections: Leiden device registry","volume":"95","author":"Lekkerkerker","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2012.12.014_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/eurheartj\/ehp421","article-title":"Prevalence and risk factors related to infections of cardiac resynchronization therapy devices","volume":"31","author":"Romeyer-Bouchard","year":"2010","journal-title":"Eur Heart J"},{"issue":"2 Suppl","key":"10.1016\/j.cjca.2012.12.014_bib5","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2012.12.014_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cjca.2010.11.007","article-title":"CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter","volume":"27","author":"Cairns","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.12.014_bib7","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","article-title":"Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen","volume":"164","author":"Douketis","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2012.12.014_bib8","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/CIRCULATIONAHA.108.823211","volume":"119","author":"Pengo","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.12.014_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCEP.109.917625","article-title":"Risk of hematoma complications after device implant in the clopidogrel era","volume":"3","author":"Kutinsky","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2012.12.014_bib10","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.jacc.2009.12.056","article-title":"Dual antiplatelet therapy and heparin \u201cbridging\u201d significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation","volume":"55","author":"Tompkins","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.12.014_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/europace\/euq431","article-title":"Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices","volume":"13","author":"Cano","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2012.12.014_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.hrthm.2010.12.016","article-title":"Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial","volume":"8","author":"Cheng","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2012.12.014_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1540-8159.2004.00441.x","article-title":"Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy","volume":"27","author":"Giudici","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2012.12.014_bib14","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1538-7836.2008.03080.x","article-title":"Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide","volume":"6","author":"Jamula","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cjca.2012.12.014_bib15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.hrthm.2010.02.018","article-title":"Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation","volume":"7","author":"Ahmed","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2012.12.014_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcin.2009.11.017","article-title":"Perioperative management of patients with drug-eluting stents","volume":"3","author":"Abualsaud","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2012.12.014_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1253\/circj.CJ-10-0525","article-title":"Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel","volume":"75","author":"Sawada","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.cjca.2012.12.014_bib18","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0735-1097(00)00633-1","article-title":"A\u00a0randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation","volume":"35","author":"Michaud","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.12.014_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.hrthm.2011.10.010","article-title":"Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices","volume":"9","author":"Cano","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2012.12.014_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.111.090464","article-title":"Peri-procedural bleeding and thromboembolic events with dabigatran compared to warfarin: results from the RE-LY randomized trial","volume":"126","author":"Healey","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.12.014_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1540-8159.2012.03354.x","article-title":"Clopidogrel increases bleeding complications in patients undergoing heart rhythm device procedures","volume":"35","author":"Boul\u00e9","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2012.12.014_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ahj.2006.10.040","article-title":"Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review","volume":"153","author":"Hovens","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2012.12.014_bib23","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2004.08.070","article-title":"Aspirin resistance and atherothrombotic disease","volume":"46","author":"Mason","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.12.014_bib24","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2005.01.034","article-title":"Resistance to clopidogrel: a review of the evidence","volume":"45","author":"Nguyen","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.12.014_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.tpj.6500435","article-title":"Exploratory aspirin resistance trial in healthy Japanese volunteers (J-ART) using platelet aggregation as a measure of thrombogenicity","volume":"7","author":"Fujiwara","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.cjca.2012.12.014_bib26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2217\/14622416.8.6.577","article-title":"Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin","volume":"8","author":"Li","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cjca.2012.12.014_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2010.10.021","article-title":"The cytochrome 2C19*2 and *3 alleles attenuate response to clopidogrel similarly in East Asian patients undergoing elective percutaneous coronary intervention","volume":"127","author":"Hwang","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2012.12.014_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/eurheartj\/ehr239","article-title":"A\u00a0systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?","volume":"33","author":"Verschuren","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2012.12.014_bib29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1592\/phco.19.10.870.31558","article-title":"Potentiation of warfarin by dong quai","volume":"19","author":"Page","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cjca.2012.12.014_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1160\/TH04-05-0285","article-title":"Herbal remedies and anticoagulant therapy","volume":"93","author":"Samuels","year":"2005","journal-title":"Thromb Haemost"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12015541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12015541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T11:31:00Z","timestamp":1562758260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X12015541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0828282X12015541"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2012.12.014","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}